Event Type
General Event

Office Hours with Dr. C

Event Date

Event Host

RCORP-TA is pleased to announce an expanded Technical Assistance opportunity for grantees: Office Hours with Dr. C.

  • Office Hours with Dr. C is a weekly opportunity now open to all grant cohorts on Thursdays at 2:00 pm to discuss questions related to medication for opioid use disorder (MOUD) with a physician expert and hear what your peers around the country are asking.
  • Registration is required for each session so that participants can receive resources discussed during the session and ongoing TA needs can be coordinated with the grantee and corresponding JBS Technical Expert Lead.
  • The audience for this technical assistance opportunity is people directly or indirectly involved in designing and delivering MOUD services using HRSA RCORP grant funds through their affiliation with grantees or coalition members, so please disseminate this invitation widely.
  • The flexible, open discussion format of Office Hours with Dr. C will allow participants easy, as needed access to an MOUD expert on a dependable schedule. This forum allows participants to drop in and drop out as needed.
  • Only Zoom audio will be used for this activity, to make it accessible by phone or computer audio and reduce demands on local internet bandwidth.  We do not plan on having video enabled.
  • We encourage you to participate in sessions via the phone numbers provided in your Zoom invite.  
  • You will receive an email confirmation that will include the link for the Office Hours once you register. Please be sure to save the registration confirmation email, as it holds the call-in number needed to connect via audio and participation instructions.

Dr. Campopiano von Klimo is a family doctor, board certified in addiction medicine, and an expert in primary care. Over her 18-year career, she has led a family medical practice, served as medical director of OTPs, and treated patients with buprenorphine in an office-based setting. As a medical director at SAMHSA for five years, Dr. Campopiano von Klimo had regulatory authority for OTPs, updated the federal guidelines for OTPs, and wrote new regulations expanding access to buprenorphine. She serves as senior medical advisor at JBS.